VEGFA and neoplasm: After 2 weeks, VMP1‐OE + BEV treatment profoundly suppressed tumor growth compared to the vehicle control (Figure 6B–E) and prolonged the overall survival of mice (Figure 6F), suggesting that BEV could abrogate the VEGFA‐dependent oncogenic effect in VMP1‐driven tumors.